APA (7th ed.) Citation

Hawley, L. E., Prochaska, F., Stringer, M., Goodlett, C. R., & Roper, R. J. (2022). Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes. Pharmacology, Biochemistry & Behavior, 217, N.PAG. https://doi.org/10.1016/j.pbb.2022.173404

Chicago Style (17th ed.) Citation

Hawley, Laura E., Faith Prochaska, Megan Stringer, Charles R. Goodlett, and Randall J. Roper. "Sexually Dimorphic DYRK1A Overexpression on Postnatal Day 15 in the Ts65Dn Mouse Model of Down Syndrome: Effects of Pharmacological Targeting on Behavioral Phenotypes." Pharmacology, Biochemistry & Behavior 217 (2022): N.PAG. https://doi.org/10.1016/j.pbb.2022.173404.

MLA (9th ed.) Citation

Hawley, Laura E., et al. "Sexually Dimorphic DYRK1A Overexpression on Postnatal Day 15 in the Ts65Dn Mouse Model of Down Syndrome: Effects of Pharmacological Targeting on Behavioral Phenotypes." Pharmacology, Biochemistry & Behavior, vol. 217, 2022, p. N.PAG, https://doi.org/10.1016/j.pbb.2022.173404.